Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT03506997 · UNKNOWN
Trial details
- NCT number
- NCT03506997
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-27
- Primary completion
- 2023-09-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.